Physician profile
Ritchie Wong
NPI 1821054552
$2,310.20
in general payments reported to CMS, 2019-2025
18 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354 · 2020: $522 · 2021: $427 · 2022: $210 · 2023: $195 · 2024: $311 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $797.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $562.00 | 2019-2022 | |
| Exact Sciences Corporation | $298.38 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Pfizer INC. | $275.58 | 2019-2025 | |
| Glaxosmithkline, LLC. | $263.83 | 2019-2021 | |
| Lilly USA, LLC | $252.67 | 2021-2025 | Mounjaro, Zepbound |
| Biohaven Pharmaceuticals, INC. | $135.18 | 2021 | |
| Medtronic Vascular, INC. | $112.11 | 2020 | |
| Sanofi Pasteur INC. | $66.54 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $62.28 | 2022 | |
| Janssen Pharmaceuticals, INC | $58.27 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $47.00 | 2023 | Strensiq |
| Kowa Pharmaceuticals America, INC. | $42.47 | 2024-2025 | Zoryve |
| Bayer Healthcare Pharmaceuticals INC. | $30.54 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.53 | 2019 | |
| Amgen INC. | $22.43 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $22.23 | 2019 | |
| Vbi Vaccine (Delaware) INC. | $17.32 | 2022 | |
| Sanofi-Aventis U.S. LLC | $14.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ritchie Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.